Tscan Therapeutics Inc
TCRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$27.29M
Close$
$-1.58
851.6% downside
Current Fair Value
851.6% downsideOvervalued by 851.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $27.29 Million |
|---|---|
| Enterprise Value | $18.61 Million |
| Earnings per Share | $-1 |
| Beta | 1.14 |
| Outstanding Shares | 129,948,878 |
Return
| Return on Equity | -170.55% |
|---|---|
| Return on Assets | -68.66% |
| Return on Invested Capital | -84.76% |
Valuation & Multiples
| P/E Ratio | -0.19 |
|---|---|
| PEG | 1.07 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.05 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 4.91 |
| Debt to Equity | 1.33 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.26
Consensus analyst estimateRevenue Estimate
$1.88 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.18
Consensus analyst estimateRevenue Estimate
$459,000
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 27.57% |
|---|---|
| Total Invested | $3,145▼ 99.99% |
| Investors Holding | 1▼ 58.00% |
About Tscan Therapeutics Inc
61 employees
